Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bolt Biotherapeutics (BOLT) Preferred Shares Issued (2020 - 2021)

Historic Preferred Shares Issued for Bolt Biotherapeutics (BOLT) over the last 2 years, with Q1 2021 value amounting to $51.9 million.

  • Bolt Biotherapeutics' Preferred Shares Issued changed N/A to $51.9 million in Q1 2021 from the same period last year, while for Dec 2021 it was $51.9 million, marking a year-over-year change of. This contributed to the annual value of $51.9 million for FY2021, which is 2576.21% up from last year.
  • As of Q1 2021, Bolt Biotherapeutics' Preferred Shares Issued stood at $51.9 million.
  • Bolt Biotherapeutics' Preferred Shares Issued's 5-year high stood at $51.9 million during Q1 2021, with a 5-year trough of -$276000.0 in Q3 2020.